A medication that acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor. The medication lowers fasting and post diner or lunch blood glucose by stimulating insulin secretion ina glucose-dependent manner.
Ozempic
MitoAction
Support, Education, Outreach and Advocacy for Children and Adults Living with Mitochondrial Disease
